Dr Annie Kan
Senior Admin Officer (Research)
Institute for Molecular Bioscience
+61 7 334 62049
Journal Articles
de Veer, Simon J., Kan, Meng-Wei and Craik, David J. (2019) Cyclotides: from structure to function. Chemical Reviews, 119 24: 12375-12421. doi:10.1021/acs.chemrev.9b00402
Feder, Daniel, Kan, Meng-Wei, Hussein, Waleed M., Guddat, Luke W., Schenk, Gerhard and McGeary, Ross P. (2019) Synthesis, evaluation and structural investigations of potent purple acid phosphatase inhibitors as drug leads for osteoporosis. European Journal of Medicinal Chemistry, 182 111611. doi:10.1016/j.ejmech.2019.111611
Oguis, Georgianna Kae, Kan, Meng-Wei and Craik, David J. (2015) Natural functions and structure-activity relationships of cyclotides. Advances in Botanical Research, 76 187-226. doi:10.1016/bs.abr.2015.10.001
Northfield, Susan E., Wang, Conan K., Schroeder, Christina I., Durek, Thomas, Kan, Meng-Wei, Swedberg, Joakim E. and Craik, David J. (2014) Disulfide-rich macrocyclic peptides as templates in drug design. European Journal of Medicinal Chemistry, 77 2: 248-257. doi:10.1016/j.ejmech.2014.03.011
Feder, Daniel, Hussein, Waleed M., Clayton, Daniel J., Kan, Meng-Wei, Schenk, Gerhard, McGeary, Ross P. and Guddat, Luke W. (2012) Identification of purple acid phosphatase inhibitors by fragment-based screening: promising new leads for osteoporosis therapeutics. Chemical Biology and Drug Design, 80 5: 665-674. doi:10.1111/cbdd.12001
Thesis
Meng-Wei (Annie) Kan (2011). The Development of New Purple Acid Phosphatase Inhibitors: A Light into Anti-osteoporotic Drugs PhD Thesis, School of Chemistry & Molecular Biosciences, The University of Queensland.